Literature DB >> 15065964

Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers.

Henry R Kranzler1, Stephen Armeli, Richard Feinn, Howard Tennen.   

Abstract

One hundred fifty-three problem drinkers were randomly assigned to receive naltrexone 50 mg or placebo on a daily or targeted (to high-risk drinking situations) basis. Using structured nightly diaries, participants recorded negative and positive mood, desire to drink, and alcohol consumption over 8 weeks. Results indicated that individuals engaged in any drinking and heavy drinking more on days characterized by relatively higher levels of positive or negative mood states. Naltrexone attenuated the positive association between heavy drinking and both positive and negative mood, and targeted administration attenuated the positive association between heavy drinking and positive mood. There was also evidence that desire to drink mediated the effect of targeted administration on the relation between positive mood and any drinking that day. These findings underscore the utility of daily measurement for understanding the processes that underlie pharmacological interventions for problem drinking.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065964     DOI: 10.1037/0022-006X.72.2.317

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  16 in total

Review 1.  Some methodological and statistical issues in the study of change processes in psychotherapy.

Authors:  Jean-Philippe Laurenceau; Adele M Hayes; Greg C Feldman
Journal:  Clin Psychol Rev       Date:  2007-01-19

Review 2.  Targeted opioid receptor antagonists in the treatment of alcohol use disorders.

Authors:  Mark J Niciu; Albert J Arias
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

3.  Changes in Affect and Drinking Outcomes in a Pharmacobehavioral Trial for Alcohol Dependence.

Authors:  Michelle D Vaughan; Joshua N Hook; J Nile Wagley; Don Davis; Christina Hill; Bankole A Johnson; J Kim Penberthy
Journal:  Addict Disord Their Treat       Date:  2012-03

4.  Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection.

Authors:  Rachel L Tomko; Kevin M Gray; Stephanie R Oppenheimer; Amy E Wahlquist; Erin A McClure
Journal:  Am J Drug Alcohol Abuse       Date:  2018-03-07       Impact factor: 3.829

5.  Endogenous Opioid Mechanisms Are Implicated in Obesity and Weight Loss in Humans.

Authors:  Paul R Burghardt; Amy E Rothberg; Kate E Dykhuis; Charles F Burant; Jon-Kar Zubieta
Journal:  J Clin Endocrinol Metab       Date:  2015-06-24       Impact factor: 5.958

6.  Daily relations among affect, urge, targeted naltrexone, and alcohol use in young adults.

Authors:  Krysten W Bold; Lisa M Fucito; William R Corbin; Kelly S DeMartini; Robert F Leeman; Henry R Kranzler; Stephanie S O'Malley
Journal:  Exp Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.157

Review 7.  The contributions of cognitive neuroscience and neuroimaging to understanding mechanisms of behavior change in addiction.

Authors:  Jon Morgenstern; Nasir H Naqvi; Robert Debellis; Hans C Breiter
Journal:  Psychol Addict Behav       Date:  2013-04-15

Review 8.  Ecological momentary assessment (EMA) in studies of substance use.

Authors:  Saul Shiffman
Journal:  Psychol Assess       Date:  2009-12

9.  Attributions of change and self-efficacy in a randomized controlled trial of medication and psychotherapy for problem drinking.

Authors:  Katherine Schaumberg; Alexis Kuerbis; Jon Morgenstern; Frederick Muench
Journal:  Behav Ther       Date:  2012-07-24

10.  Dynamic association between negative affect and alcohol lapses following alcohol treatment.

Authors:  Katie Witkiewitz; Nadia Aracelliz Villarroel
Journal:  J Consult Clin Psychol       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.